Chemioterapia Adiuvante Del Carcinoma Mammario Questioni Aperte E Sviluppi Futuri

Abstract

Get full access to this article

View all access options for this article.

References

Perloff

: Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non cross-resistant regimen: a CALGB study. J Clin Oncol 14: 1589, 1995.

Bonadonna

: Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes (ten-years results). JAMA 273: 542, 1995.

Bergh

, Wiklund

, Erikstein

: Tailored fluorouracil, epirubicin and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study. Lancet 356: 1384–1391, 2000.